Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13Neoplasms 12Glioma 12Prostatic Neoplasms 11Glioblastoma 11Colorectal Neoplasms 10Brain Neoplasms 10Pancreatic Neoplasms 9Neoplasm Metastasis 9Melanoma 8Lymphoma, B-Cell 8Lymphoma 8Recurrence 7Multiple Myeloma 7Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Carcinoma, Non-Small-Cell Lung 5Skin Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Hepatocellular 4Advanced Solid Tumors 4Solid Tumor 3Pituitary Neoplasms 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Lymphoma, Follicular 3Lung Neoplasms 3Carcinoma, Transitional Cell 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Solid Malignancies × 90 days × Clear all
NCT07505771 2026-04-06

A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer

Immunome, Inc.

Phase EARLY_PHASE1 Recruiting
105 enrolled

Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡